Get started
Aethlon Medical, Inc.Aethlon Medical, Inc.Aethlon Medical, Inc.

Aethlon Medical, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

AEMD trade ideas

AEMD Finishing Wave (5) ShortAethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
NASDAQ:AEMDShort
by TheCryptoChartWhisperer
AEMD 45min Scalptest Aethlon Medical, Inc. is a medical technology company, which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
NASDAQ:AEMDLong
by TheCryptoChartWhisperer
$AEMD is gonna fall todayPupm&Dump trading strategy idea. $AEMD is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $5,27; stop-loss — $5,50; take-profit — $4,82/MOC Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:AEMDShort
by KozakHlib
Between Two Fibs - AEMDAEMD seems to like this range between the 786 and 618 fib lines. The 618 has long-been a point of resistance on the chart. Meanwhile, the last few days have seen it test the 786 level but hold both above it AND its 50DMA. No news today but focus on biotechs thanks to CYTK earlier could be a sympathy trigger at play. Also with the Delta varient becoming "a thing," covid stocks in numerous stages of development are becoming more of a focus right now. We'll have to see if 786 fib+ 50DMA post a strong support level and if 618 will remain resistance if or when AEMD takes another swing at it.
NASDAQ:AEMD
by PennyStocks101
AEMD Technical Analysis 🧙Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:AEMDLong
by trading_as_bus
Large Sample-Size AnalysisI'm on the monthly for this one. Lectin, for some, is an allergen (e.g. latex/rubber). It's being injected into DNA-modified foods. Apparently, lectin can find infectious diseases by the way it interacts with cell-defense mechanisms. Aethlon uses lectin in combination with a heavy, heavy monoclonal antibody (all the rage these days). You can find full-spread ads for MABs in your current Oprah magazine. Money's coming in to save you. I know first-hand that MABs don't solve everything. Neither does an indicator for a problem. However, it's a start. Maybe worth looking into for when you get older and 5G is apparently deadly. I looked into this, it's speculative but some people would bet on it. At any rate, they're betting. You can make a bet too. Let's see where it goes. P.S. You may soon be allergic to DNA-modified tomatoes. As always, keep an eye out.
NASDAQ:AEMDLong
by jacobit
5
FDA Approval of IDE Supplement for COVID-19 PatientsAethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients (FDA) has approved a supplement to the Company's existing Investigational Device Exemption (IDE) for the Company's Hemopurifier® in viral disease to allow for the testing of the Hemopurifier in patients with SARS-CoV-2/COVID-19 in a new feasibility study. The feasibility study, which is the device equivalent of a phase 1 trial, will enroll up to 40 subjects at up to 20 centers in the U.S. Subjects will have established laboratory diagnosis of COVID-19, be admitted to an intensive care unit (ICU) and will have acute lung injury and/or severe or life threatening disease among other criteria. "We believe that the Hemopurifier may have the potential to help severely affected patients with COVID-19. We believe that clearing circulating virus in these patients, in combination with other supportive measures, could improve outcomes in this deadly disease." The Hemopurifier is an FDA designated "Breakthrough Device" for the treatment of life-threatening viruses that are not addressed with approved therapies. The Hemopurifier also holds a Breakthrough Device designation finance.yahoo.com www.bloomberg.com
NASDAQ:AEMD
by AlenCiken
2
AEMD - buy - see volume, news, conference on 6/25This weekly chart shows more upside possible. This is not a pump and dump as best as I can tell. I am using technicals and news. You can wait for a pull back. This could also go up more overnight, and/or there may be more upside after the conference call next week. Remember to consider how much capital you want to tie up, and create an exit plan. I bought this stock knowing it is an investment. This is not a purchase in my trading account.
NASDAQ:AEMDLong
by OptionsRising
AEMD Has Bottomed!Hello, What is AEMD? At Aethlon Medical, we are a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. I noted the bear divergence but also see the rounded bottom and conclude that AEMD is in accumulation and should at some point break out to the upside. Be sure to comment, follow, like, and check out my profile for more trade ideas! Good Luck, Cheers!
NASDAQ:AEMDLong
by keifer
6
Aethlon Medical, Inc. on Breakout WatchAethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.
NASDAQ:AEMD
by DEXWireNews
1